SG170120A1 - Compositions containing riboflavin and sesamin-class compounds - Google Patents

Compositions containing riboflavin and sesamin-class compounds

Info

Publication number
SG170120A1
SG170120A1 SG201101846-2A SG2011018462A SG170120A1 SG 170120 A1 SG170120 A1 SG 170120A1 SG 2011018462 A SG2011018462 A SG 2011018462A SG 170120 A1 SG170120 A1 SG 170120A1
Authority
SG
Singapore
Prior art keywords
sesamin
riboflavin
compositions containing
composition
class compound
Prior art date
Application number
SG201101846-2A
Other languages
English (en)
Inventor
Daisuke Takemoto
Norifumi Tateishi
Yoshiko Ono
Kayo Saito
Akifumi Maeda
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG170120A1 publication Critical patent/SG170120A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
SG201101846-2A 2006-03-15 2007-03-15 Compositions containing riboflavin and sesamin-class compounds SG170120A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006070487 2006-03-15

Publications (1)

Publication Number Publication Date
SG170120A1 true SG170120A1 (en) 2011-04-29

Family

ID=38609174

Family Applications (1)

Application Number Title Priority Date Filing Date
SG201101846-2A SG170120A1 (en) 2006-03-15 2007-03-15 Compositions containing riboflavin and sesamin-class compounds

Country Status (12)

Country Link
US (2) US20090054443A1 (ja)
EP (2) EP2826481A1 (ja)
JP (2) JP5430927B2 (ja)
KR (1) KR101451438B1 (ja)
CN (1) CN101410115B (ja)
AU (1) AU2007237685B2 (ja)
CA (1) CA2645833C (ja)
HK (2) HK1126663A1 (ja)
MY (1) MY163134A (ja)
SG (1) SG170120A1 (ja)
TW (1) TWI407963B (ja)
WO (1) WO2007119378A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5069416B2 (ja) * 2006-03-15 2012-11-07 サントリーホールディングス株式会社 吸湿性の改善された飲食品用組成物
US20090054443A1 (en) 2006-03-15 2009-02-26 Suntory Limited Compositions containing riboflavin and sesamin-class compounds
CA2680751C (en) * 2007-03-15 2016-01-26 Suntory Holdings Limited Use of dioxabicyclo[3.3.0]octane derivatives as anti-fatigue agents
KR101528380B1 (ko) * 2007-09-19 2015-06-11 산토리 홀딩스 가부시키가이샤 세사민류와 아라키돈산류를 함유하는 조성물
AU2008301699B2 (en) * 2007-09-19 2014-10-02 Suntory Holdings Limited Composition Comprising Sesamin Component and Vitamin B1 Component
JP5794761B2 (ja) * 2007-09-19 2015-10-14 サントリーホールディングス株式会社 セサミン類及びビタミンｅを含有する抗疲労剤
CN103446197B (zh) * 2013-09-11 2016-04-13 白心亮 一种保肝制品
WO2016152846A1 (ja) * 2015-03-23 2016-09-29 サントリーホールディングス株式会社 概日リズム改善用組成物
JP6749665B1 (ja) * 2019-07-18 2020-09-02 株式会社東洋新薬 経口組成物
US20210283165A1 (en) * 2021-03-11 2021-09-16 Nidal Toman Constituent combination for treating stress

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4427694A (en) 1982-06-11 1984-01-24 The Vinoxen Company, Inc. Sesamin as a psychotropic agent
US5211953A (en) * 1989-07-21 1993-05-18 Suntory, Limited Liver function improver
JP3001589B2 (ja) * 1989-07-21 2000-01-24 サントリー株式会社 リグナン類含有飲食物
EP0826369B1 (en) * 1989-07-21 2003-06-04 Suntory Limited Therapeutic use of dioxabicyclo (3.3.0)octane compounds
JP3075358B2 (ja) 1990-04-03 2000-08-14 サントリー株式会社 肝機能改善剤
JPH04278067A (ja) 1991-03-05 1992-10-02 Suntory Ltd 胡麻入り飲料
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
GB9116054D0 (en) 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments
JPH0551388A (ja) 1991-08-23 1993-03-02 Suntory Ltd 過酸化脂質生成抑制剤
JPH0558902A (ja) 1991-08-30 1993-03-09 Nippon Oil & Fats Co Ltd アレルギー予防油脂組成物
NZ244270A (en) * 1991-09-13 1995-07-26 Eisai Co Ltd Injectable composition comprising riboflavin
JP3636207B2 (ja) 1991-09-13 2005-04-06 エーザイ株式会社 免疫賦活・感染防御剤及びその製造方法
ES2114038T3 (es) * 1992-02-17 1998-05-16 Manabu Nomura Promotor del crecimiento y restablecimiento capilar.
JPH06327435A (ja) 1992-11-10 1994-11-29 Otsuka Pharmaceut Co Ltd 栄養補給組成物
JPH06227977A (ja) 1993-02-01 1994-08-16 Suntory Ltd 活性酸素消去剤
JP2677949B2 (ja) 1993-08-26 1997-11-17 常盤薬品工業株式会社 アラキドン酸含有健康食品
JPH0826987A (ja) 1994-05-12 1996-01-30 Hirohiko Kuratsune アシルカルニチン含有製剤
JPH0847381A (ja) 1994-08-08 1996-02-20 Meiji Seika Kaisha Ltd 持久力向上飲食品
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US5948451A (en) 1995-07-04 1999-09-07 Suntory Limited Method of modifying the balance of omega unsaturated fatty acids using a dioxabicyclo octane derivative
JP4526047B2 (ja) 1995-11-08 2010-08-18 雪印乳業株式会社 体力増強剤
AU7068896A (en) 1995-11-09 1997-05-15 Corunum Corporation Protein composition derived from sesame seed and use thereof
JP3286831B2 (ja) 1996-04-01 2002-05-27 エーザイ株式会社 ビタミンｂ２含有医薬
JPH10218785A (ja) 1997-02-12 1998-08-18 Misaki Takemura 滋養強壮剤
US6172106B1 (en) * 1998-02-09 2001-01-09 R. Armour Forse Sesamol inhibition of Δ-5-desaturase activity and uses therefor
PT951842E (pt) * 1999-01-20 2003-04-30 Nutricia Nv Formula de alimento adaptada para bebe
JP2001046021A (ja) 1999-08-10 2001-02-20 Itoham Foods Inc 体力増強・疲労回復用素材及びそれを用いた食品
KR20010029185A (ko) * 1999-09-29 2001-04-06 손남율 항바이러스제 및 항암제
JP3789699B2 (ja) 1999-11-18 2006-06-28 サントリー株式会社 リグナン系抗酸化剤及びその製造法
CA2427030C (en) 2000-10-27 2010-06-01 Takanobu Yamamoto Fatigue recovering or fatigue preventive agent for central nervous system and food for fatigue recovery or fatigue prevention
JP2002226457A (ja) * 2001-02-02 2002-08-14 Ajinomoto Co Inc 新規シスチン誘導体及び炎症因子活性化抑制剤
KR20020090077A (ko) 2001-05-23 2002-11-30 정성일 노화예방, 정력보강, 간과 신을돕고 허손을 보호,근력튼튼, 안색이 아름답고 흰머리예방
JP2003146844A (ja) * 2001-11-13 2003-05-21 Ichimaru Pharcos Co Ltd 毛髪用化粧料組成物
US20030105104A1 (en) * 2001-11-27 2003-06-05 Burzynski Stanislaw R. Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
JP2003183172A (ja) * 2001-12-18 2003-07-03 Takemoto Oil & Fat Co Ltd 片頭痛の抑制乃至予防治療用経口投与剤
KR100989536B1 (ko) * 2002-04-11 2010-10-25 교와 핫꼬 바이오 가부시키가이샤 지용성 비타민을 함유하는 액상 음식품 및 지용성비타민의 안정화 방법
US7396554B2 (en) * 2002-08-16 2008-07-08 Council Of Scientific & Industrial Research Antioxidant sesame extract
JP2004189619A (ja) * 2002-12-09 2004-07-08 Dai Ichi Seiyaku Co Ltd 滋養強壮剤
JP2004345988A (ja) * 2003-05-21 2004-12-09 Eisai Co Ltd リボフラビン系化合物を含む医薬組成物
JPWO2004105749A1 (ja) 2003-05-27 2006-07-20 サントリー株式会社 自律神経調節作用を有する組成物およびその使用方法
ATE440509T1 (de) * 2003-06-04 2009-09-15 Nestec Sa Getränk zur gewichtskontrolle
JP2005023008A (ja) * 2003-07-01 2005-01-27 Sankyo Co Ltd ビタミンｂ群を含有する内服液剤組成物
TWI365716B (en) 2003-12-02 2012-06-11 Suntory Holdings Ltd Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same
US20060115556A1 (en) 2004-12-01 2006-06-01 Foulger Sidney W Nutritional supplement drink containing xanthone extracts
JP2007008878A (ja) 2005-06-30 2007-01-18 Sato Pharmaceutical Co Ltd 非運動性及び非急性ストレス性疲労の治療剤
WO2007004570A1 (ja) 2005-06-30 2007-01-11 Suntory Limited 持久力向上および／または抗疲労作用を有する組成物
US20090169682A1 (en) 2005-10-14 2009-07-02 Meiji Pharmaceutical Co., Ltd. Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same
US20090054443A1 (en) 2006-03-15 2009-02-26 Suntory Limited Compositions containing riboflavin and sesamin-class compounds
JP5069416B2 (ja) 2006-03-15 2012-11-07 サントリーホールディングス株式会社 吸湿性の改善された飲食品用組成物
CN1836555A (zh) 2006-04-26 2006-09-27 金龙德 一种携带食用方便的益寿养生米肠及其加工方法
WO2008007728A1 (fr) 2006-07-13 2008-01-17 Kaneka Corporation Préparation orale contenue dans une structure à membrane lipidique, et agent contre la fatigue comprenant une coenzyme comme ingrédient actif
JPWO2008062559A1 (ja) 2006-11-22 2010-03-04 旭化成ファーマ株式会社 栄養補助食品、抗疲労作用剤又は持久力増強剤、機能性食品又は化粧料
JP2008136391A (ja) 2006-11-30 2008-06-19 Nisshin Pharma Inc 若葉組成物
CA2680751C (en) 2007-03-15 2016-01-26 Suntory Holdings Limited Use of dioxabicyclo[3.3.0]octane derivatives as anti-fatigue agents
JP2008285463A (ja) 2007-05-18 2008-11-27 Makiko Funayama 関節症・リウマチ・膠原病の治療薬

Also Published As

Publication number Publication date
EP2826481A1 (en) 2015-01-21
HK1126663A1 (en) 2009-09-11
JP6095549B2 (ja) 2017-03-15
TWI407963B (zh) 2013-09-11
CA2645833A1 (en) 2007-10-25
CN101410115B (zh) 2012-01-04
JPWO2007119378A1 (ja) 2009-08-27
KR101451438B1 (ko) 2014-10-15
JP2014040463A (ja) 2014-03-06
EP1997496A1 (en) 2008-12-03
JP5430927B2 (ja) 2014-03-05
CN101410115A (zh) 2009-04-15
MY163134A (en) 2017-08-15
TW200803865A (en) 2008-01-16
US20150080407A1 (en) 2015-03-19
HK1201754A1 (en) 2015-09-11
US9895375B2 (en) 2018-02-20
WO2007119378A1 (ja) 2007-10-25
AU2007237685A1 (en) 2007-10-25
KR20080110814A (ko) 2008-12-19
EP1997496A4 (en) 2012-05-16
CA2645833C (en) 2014-12-30
AU2007237685B2 (en) 2012-08-09
EP1997496B1 (en) 2015-07-29
US20090054443A1 (en) 2009-02-26

Similar Documents

Publication Publication Date Title
SG170120A1 (en) Compositions containing riboflavin and sesamin-class compounds
WO2007117706A3 (en) Solid oral dosage form containing an enhancer
MX360951B (es) Composiciones para humectar la boca, sistemas para su administración y métodos para fabricar las mismas.
TW200631575A (en) Liquid seasoning
IN2012DN03632A (ja)
WO2009027820A3 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
NZ599300A (en) Magnesium compositions and uses thereof
WO2008013840A3 (en) Erastin analogs and uses thereof
WO2006122196A3 (en) Methods for enhancing palatability of compositions for animal consumption
MY159379A (en) Composition for human and/or animal nutrition, uses thereof and yeasts
PH12016500905A1 (en) Nutritional compositions with phospholipids
MY153948A (en) Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof
WO2007112272A3 (en) Formulations of low dose diclofenac and beta-cyclodextrin
IN2015DN02751A (ja)
TW200631574A (en) Liquid seasoning
MX354942B (es) Composiciones para la administración oral a animales, procedimientos de obtención de las mismas y sus usos.
WO2008132021A3 (de) Fungizide mischungen
SG170121A1 (en) Compositions for food or beverage with improved hygroscopicity
WO2009095798A3 (en) Formulas comprising calcium, magnesium, zinc, and vitamin d3 for the prevention and amelioration of osteoporosis
WO2009055084A3 (en) Vitamin c compositions
JP2018161150A (ja) 液体食品組成物
WO2005044247A8 (en) Pharmaceutical composition containing guaiacol derivatives and syringol derivatives extracted from natural plant vinegar
WO2007002897A8 (en) Compositions to improve the bioavailability of polymethoxyflavones and tocotrienols for treatment of cardiovascular disease
MX2010007775A (es) Aditivo alimentario a base de capsicum y utilizaciones.
TW200628167A (en) Composition for preventing and/or treating metabolic syndrome and insulin resistance syndrome